세계의 지속적신대체요법(CRRT) 시장 : 모달리티, 제품, 지역별, 경쟁 구도 - 분석과 예측(2024-2033년)

Global Continuous Renal Replacement Therapy Market: Focus on Modality, Product, Region, and Competitive Landscape - Analysis and Forecast, 2024-2033

US $ 2,475 ￦ 3,401,000

PDF and Excel (1-3 User License)

PDF 및 Excel 보고서를 동일 사업장에서 3명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 3,825 ￦ 5,256,000

PDF and Excel (Global License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계의 지속적신대체요법(CRRT) 시장은 급성 신손상(AKI)의 유병률 증가 및 첨단 신장 케어 솔루션에 대한 수요의 증가를 배경으로 현저한 성장을 달성하고 있습니다.

CRRT는 신장 기능이 저하한 환자에게 중요한 개입이며, 혈액 정화를 위한 지속적 한편 효율적인 방법을 제공합니다. 이 시장은 혈액 여과, 혈액투석 여과, 혈액투석 등 CRRT 시술의 효율과 유효성을 높이는 혁신적인 방법의 채택에 의해 특징지어집니다.

시장 확대 요인으로는 고령자 인구의 증가, 패혈증 및 다장기부전의 발생률 상승, 헬스케어 인프라의 진보 등도 들 수 있습니다. 또한 중증 환자 관리에서 CRRT의 이점에 대한 의료 종사자의 의식 향상도 시장의 성장을 지원하고 있습니다.

세계의 지속적신대체요법(CRRT) 시장을 조사했으며, 시장 배경·개요, 시장 성장에 대한 각종 영향요인 분석, 특허 동향, 법규제 환경, 시장 규모의 추이·예측, 각종 구분/지역별 상세 분석, 경쟁 구도, 주요 기업의 분석 등을 정리하여 전해드립니다.

시장 세분화

세분화 1 : 모달리티별

• 지속적 정정맥 혈액 여과(CVVH)
• 지속적 정정맥 혈액 여과 투석(CVVHDF)
• 지속적 정정맥 혈액투석(CVVHD)
• SCUF(Slow Continuous Ultrafiltration)

세분화 2 : 제품별

• 지속적 신장 대체 시스템
• 일회용
• 투석액 및 교환액

세분화 3 : 지역별

• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 기타 지역

목차

주요 요약

제1장 시장

• 동향 : 현재 및 향후 영향 평가
• 공급망의 개요
  • 밸류체인 분석
  • 마켓 맵
• R&D 리뷰
  • 국가·기업별 특허 출원 동향
• 규제 상황
• 주요 세계 이벤트의 영향 분석 : COVID-19
• 시장 역학의 개요
  • 시장 촉진요인
  • 시장 억제요인
  • 시장 기회

제2장 용도

• 용도 세분화
• 용도의 개요
• 세계의 지속적신대체요법(CRRT) 시장(모달리티별)
  • 지속적 정정맥 혈액 여과(CVVH)
  • 지속적 정정맥 혈액 여과 투석(CVVHDF)
  • 지속적 정정맥 혈액투석(CVVHD)
  • SCUF(Slow Continuous Ultrafiltration)

제3장 제품

• 제품 세분화
• 제품 개요
• 세계의 지속적신대체요법(CRRT) 시장(유형별)
  • 시장 개요
• 세계의 지속적신대체요법(CRRT) 시장(제품별)
  • 지속적 신장 대체 시스템
  • 일회용
  • 투석액 및 교환액

제4장 지역

• 지역 개요
• 촉진요인·억제요인
• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 기타 지역

제5장 시장 : 경쟁 벤치마킹·기업 개요

• 다음 프론티어
• 지역적 평가
  • B. Braun SE
  • Baxter
  • Fresenius Medical Care AG
  • Asahi Kasei Corporation
  • NIPRO CORPORATION
  • Toray Medical Co. Ltd.
  • Medtronic plc
  • Medica S.p.A
  • Anjue Medical Equipment Co., Ltd.
  • Ningbo Tinyani Medical Equipment
  • Nikkiso Co., Ltd.
  • SWS Hemodialysis Co., ltd
  • Informed SA
  • Medical Components, Inc.
  • CytoSorbents Corporation

제6장 조사 방법

KSA

영문 목차

영문목차

“Global Continuous Renal Replacement Therapy Market Poised for Remarkable Growth.”

The global continuous renal replacement therapy (CRRT) market is witnessing significant growth, driven by the increasing prevalence of acute kidney injuries (AKI) and the rising demand for advanced renal care solutions. CRRT serves as a vital intervention for patients with impaired kidney function, offering a continuous and efficient method for blood purification. The market is characterized by the adoption of innovative modes, such as hemofiltration, hemodiafiltration, hemodialysis, etc. enhancing the efficiency and efficacy of CRRT procedures.

Factors contributing to the market's expansion include a growing geriatric population, a rise in the incidence of sepsis and multiple organ failure, and advancements in healthcare infrastructure. Additionally, the increasing awareness among healthcare professionals about the benefits of CRRT in managing critically ill patients is bolstering market growth.

Market Segmentation:

Segmentation 1: by Modality

• Continuous Venovenous Hemofiltration (CVVH)
• Continuous Venovenous Hemodiafiltration (CVVHDF)
• Continuous Venovenous Hemodialysis (CVVHD)
• Slow Continuous Ultrafiltration (SCUF)

Segmentation 2: by Product

• Continuous Renal Replacement System
• Disposables
• Dialysates and Replacement Fluids

Segmentation 3: by Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Rest-of-the-World

Key Questions Answered in this Report:

• What are the focus segments of the global continuous renal replacement therapy market in the upcoming years?
• What is the value of revenue generated from the continuous renal replacement therapy market across the globe and at what rate is the demand expected to grow in the forecast period?
• Which product will be the most revenue-generating in the global continuous renal replacement therapy market?
• Which continuous renal replacement therapy segment is estimated to hold the largest share of the market globally?
• Which product segment is expected to grow at the highest CAGR during the forecast period?
• Which modality segment accounted for the largest share of the continuous renal replacement therapy market?
• What are the key growth factors of this market? What are the major opportunities for existing market players and new entrants in the global continuous renal replacement therapy market? What are the major challenges faced by the existing players in the market?
• Who are the major players dominating the global continuous renal replacement therapy market space?
• Which regions/countries are expected to offer significant growth opportunities for the vendors operating in the continuous renal replacement therapy market for the forecast period?
• What are the key growth factors of this market? What are the major opportunities for existing market players and new entrants in the global continuous renal replacement therapy market? What are the major challenges faced by the existing players in the market?
• Who are the major players dominating the global continuous renal replacement therapy market space?
• Which regions/countries are expected to offer significant growth opportunities for the vendors operating in the continuous renal replacement therapy market for the forecast period?

Table of Contents

Executive Summary

1. Markets

• 1.1. Trends : Current and Future Impact Assessment
  • 1.1.1. Sample Text
  • 1.1.2. Trend 1
  • 1.1.3. Trend 2
  • 1.1.4. Trend 3
• 1.2. Supply chain Overview
  • 1.2.1. Value Chain Analysis
  • 1.2.2. Market Map
• 1.3. Research and Development Review
  • 1.3.1. Patent Filing Trend (by Country, Company)
• 1.4. Regulatory Landscape
• 1.5. Impact Analysis for Key Global Events- COVID- 19
• 1.6. Market Dynamics Overview
  • 1.6.1. Market Drivers
  • 1.6.2. Market Restraints
  • 1.6.3. Market Opportunities

2. Application

• 2.1. Application Segmentation
• 2.2. Application Summary
• 2.3. Global Continuous Renal Replacement Therapy Market (by Modality)
  • 2.3.1. Continuous Venovenous Hemofiltration (CVVH)
  • 2.3.2. Continuous Venovenous Hemodiafiltration (CVVHDF)
  • 2.3.3. Continuous Venovenous Hemodialysis (CVVHD)
  • 2.3.4. Slow Continuous Ultrafiltration (SCUF)

3. Products

• 3.1. Product Segmentation
• 3.2. Product Summary
• 3.3. Global Continuous Renal Replacement Therapy Market - (by Type)
  • 3.3.1. Market Overview
    • 3.3.1.1. Analyst View
• 3.4. Global Continuous Renal Replacement Therapy Market (by Product)
  • 3.4.1. Continuous Renal Replacement System
  • 3.4.2. Disposables
    • 3.4.2.1. Hemofilters
    • 3.4.2.2. Bloodline Sets & Tubes
    • 3.4.2.3. Others
  • 3.4.3. Dialysates and Replacement Fluids

4. Regions

• 4.1. Regional Summary
• 4.2. Drivers and Restraints
• 4.3. North America
  • 4.3.1. Regional Overview
  • 4.3.2. Driving Factors for Market Growth
  • 4.3.3. Factors Challenging the Market
  • 4.3.4. Application
  • 4.3.5. Product
  • 4.3.6. U.S.
  • 4.3.7. U.S. Continuous Renal Replacement Therapy Market by Modality
  • 4.3.8. U.S. Continuous Renal Replacement Therapy Market by Product
  • 4.3.9. Canada
  • 4.3.10. Canada Continuous Renal Replacement Therapy Market by Modality
  • 4.3.11. Canada Continuous Renal Replacement Therapy Market by Product
• 4.4. Europe
  • 4.4.1. Regional Overview
  • 4.4.2. Driving Factors for Market Growth
  • 4.4.3. Factors Challenging the Market
  • 4.4.4. Application
  • 4.4.5. Product
  • 4.4.6. Germany
  • 4.4.7. Germany Continuous Renal Replacement Therapy Market by Modality
  • 4.4.8. Germany Continuous Renal Replacement Therapy Market by Product
  • 4.4.9. U.K.
  • 4.4.10. U.K. Continuous Renal Replacement Therapy Market by Modality
  • 4.4.11. U.K. Continuous Renal Replacement Therapy Market by Product
  • 4.4.12. France
  • 4.4.13. France Continuous Renal Replacement Therapy Market by Modality
  • 4.4.14. France Continuous Renal Replacement Therapy Market by Product
  • 4.4.15. Italy
  • 4.4.16. Italy Continuous Renal Replacement Therapy Market by Modality
  • 4.4.17. Italy Continuous Renal Replacement Therapy Market by Product
  • 4.4.18. Spain
  • 4.4.19. Spain Continuous Renal Replacement Therapy Market by Modality
  • 4.4.20. Spain Continuous Renal Replacement Therapy Market by Product
  • 4.4.21. Netherlands
  • 4.4.22. Netherlands Continuous Renal Replacement Therapy Market by Modality
  • 4.4.23. Netherlands Continuous Renal Replacement Therapy Market by Product
  • 4.4.24. Rest of Europe
  • 4.4.25. Rest of Europe Continuous Renal Replacement Therapy Market by Modality
  • 4.4.26. Rest of Europe Continuous Renal Replacement Therapy Market by Product
• 4.5. Asia Pacific
  • 4.5.1. Regional Overview
  • 4.5.2. Driving Factors for Market Growth
  • 4.5.3. Factors Challenging the Market
  • 4.5.4. Application
  • 4.5.5. Product
  • 4.5.6. China
  • 4.5.7. China Continuous Renal Replacement Therapy Market by Modality
  • 4.5.8. China Continuous Renal Replacement Therapy Market by Product
  • 4.5.9. Japan
  • 4.5.10. Japan Continuous Renal Replacement Therapy Market by Modality
  • 4.5.11. Japan Continuous Renal Replacement Therapy Market by Product
  • 4.5.12. South Korea
  • 4.5.13. South Korea Continuous Renal Replacement Therapy Market by Modality
  • 4.5.14. South Korea Continuous Renal Replacement Therapy Market by Product
  • 4.5.15. Australia
  • 4.5.16. Australia Continuous Renal Replacement Therapy Market by Modality
  • 4.5.17. Australia Continuous Renal Replacement Therapy Market by Product
  • 4.5.18. India
  • 4.5.19. India Continuous Renal Replacement Therapy Market by Modality
  • 4.5.20. India Continuous Renal Replacement Therapy Market by Product
  • 4.5.21. Rest-of-Asia-Pacific
  • 4.5.22. Rest-of-Asia-Pacific Continuous Renal Replacement Therapy Market by Modality
  • 4.5.23. Rest-of-Asia-Pacific Continuous Renal Replacement Therapy Market by Product
• 4.6. Latin America
  • 4.6.1. Regional Overview
  • 4.6.2. Driving Factors for Market Growth
  • 4.6.3. Factors Challenging the Market
  • 4.6.4. Application
  • 4.6.5. Product
  • 4.6.6. Brazil
  • 4.6.7. Brazil Continuous Renal Replacement Therapy Market by Modality
  • 4.6.8. Brazil Continuous Renal Replacement Therapy Market by Product
  • 4.6.9. Mexico
  • 4.6.10. Mexico Continuous Renal Replacement Therapy Market by Modality
  • 4.6.11. Mexico Continuous Renal Replacement Therapy Market by Product
  • 4.6.12. Rest-of-Latin America
  • 4.6.13. Rest-of-Latin-America Continuous Renal Replacement Therapy Market by Modality
  • 4.6.14. Rest-of-Latin-America Continuous Renal Replacement Therapy Market by Product
• 4.7. Rest-of-the-World (RoW)
  • 4.7.1. Regional Overview
  • 4.7.2. Driving Factors for Market Growth
  • 4.7.3. Factors Challenging the Market
  • 4.7.4. Application
  • 4.7.5. Product

5. Markets - Competitive Benchmarking & Company Profiles

• 5.1. Next Frontiers…..
• 5.2. Geographic Assessment
  • 5.2.1. B. Braun SE
    • 5.2.1.1. Overview
    • 5.2.1.2. Top Products / Product Portfolio
    • 5.2.1.3. Top Competitors
    • 5.2.1.4. Target Customers
    • 5.2.1.5. Key Personnel
    • 5.2.1.6. Analyst View
    • 5.2.1.7. Market Share
  • 5.2.2. Baxter
    • 5.2.2.1. Overview
    • 5.2.2.2. Top Products / Product Portfolio
    • 5.2.2.3. Top Competitors
    • 5.2.2.4. Target Customers
    • 5.2.2.5. Key Personnel
    • 5.2.2.6. Analyst View
    • 5.2.2.7. Market Share
  • 5.2.3. Fresenius Medical Care AG
    • 5.2.3.1. Overview
    • 5.2.3.2. Top Products / Product Portfolio
    • 5.2.3.3. Top Competitors
    • 5.2.3.4. Target Customers
    • 5.2.3.5. Key Personnel
    • 5.2.3.6. Analyst View
    • 5.2.3.7. Market Share
  • 5.2.4. Asahi Kasei Corporation
    • 5.2.4.1. Overview
    • 5.2.4.2. Top Products / Product Portfolio
    • 5.2.4.3. Top Competitors
    • 5.2.4.4. Target Customers
    • 5.2.4.5. Key Personnel
    • 5.2.4.6. Analyst View
    • 5.2.4.7. Market Share
  • 5.2.5. NIPRO CORPORATION
    • 5.2.5.1. Overview
    • 5.2.5.2. Top Products / Product Portfolio
    • 5.2.5.3. Top Competitors
    • 5.2.5.4. Target Customers
    • 5.2.5.5. Key Personnel
    • 5.2.5.6. Analyst View
    • 5.2.5.7. Market Share
  • 5.2.6. Toray Medical Co. Ltd.
    • 5.2.6.1. Overview
    • 5.2.6.2. Top Products / Product Portfolio
    • 5.2.6.3. Top Competitors
    • 5.2.6.4. Target Customers
    • 5.2.6.5. Key Personnel
    • 5.2.6.6. Analyst View
    • 5.2.6.7. Market Share
  • 5.2.7. Medtronic plc
    • 5.2.7.1. Overview
    • 5.2.7.2. Top Products / Product Portfolio
    • 5.2.7.3. Top Competitors
    • 5.2.7.4. Target Customers
    • 5.2.7.5. Key Personnel
    • 5.2.7.6. Analyst View
    • 5.2.7.7. Market Share
  • 5.2.8. Medica S.p.A
    • 5.2.8.1. Overview
    • 5.2.8.2. Top Products / Product Portfolio
    • 5.2.8.3. Top Competitors
    • 5.2.8.4. Target Customers
    • 5.2.8.5. Key Personnel
    • 5.2.8.6. Analyst View
    • 5.2.8.7. Market Share
  • 5.2.9. Anjue Medical Equipment Co., Ltd.
    • 5.2.9.1. Overview
    • 5.2.9.2. Top Products / Product Portfolio
    • 5.2.9.3. Top Competitors
    • 5.2.9.4. Target Customers
    • 5.2.9.5. Key Personnel
    • 5.2.9.6. Analyst View
    • 5.2.9.7. Market Share
  • 5.2.10. Ningbo Tinyani Medical Equipment
    • 5.2.10.1. Overview
    • 5.2.10.2. Top Products / Product Portfolio
    • 5.2.10.3. Top Competitors
    • 5.2.10.4. Target Customers
    • 5.2.10.5. Key Personnel
    • 5.2.10.6. Analyst View
    • 5.2.10.7. Market Share
  • 5.2.11. Nikkiso Co., Ltd.
    • 5.2.11.1. Overview
    • 5.2.11.2. Top Products / Product Portfolio
    • 5.2.11.3. Top Competitors
    • 5.2.11.4. Target Customers
    • 5.2.11.5. Key Personnel
    • 5.2.11.6. Analyst View
    • 5.2.11.7. Market Share
  • 5.2.12. SWS Hemodialysis Co., ltd
    • 5.2.12.1. Overview
    • 5.2.12.2. Top Products / Product Portfolio
    • 5.2.12.3. Top Competitors
    • 5.2.12.4. Target Customers
    • 5.2.12.5. Key Personnel
    • 5.2.12.6. Analyst View
    • 5.2.12.7. Market Share
  • 5.2.13. Informed SA
    • 5.2.13.1. Overview
    • 5.2.13.2. Top Products / Product Portfolio
    • 5.2.13.3. Top Competitors
    • 5.2.13.4. Target Customers
    • 5.2.13.5. Key Personnel
    • 5.2.13.6. Analyst View
    • 5.2.13.7. Market Share
  • 5.2.14. Medical Components, Inc.
    • 5.2.14.1. Overview
    • 5.2.14.2. Top Products / Product Portfolio
    • 5.2.14.3. Top Competitors
    • 5.2.14.4. Target Customers
    • 5.2.14.5. Key Personnel
    • 5.2.14.6. Analyst View
    • 5.2.14.7. Market Share
  • 5.2.15. CytoSorbents Corporation
    • 5.2.15.1. Overview
    • 5.2.15.2. Top Products / Product Portfolio
    • 5.2.15.3. Top Competitors
    • 5.2.15.4. Target Customers
    • 5.2.15.5. Key Personnel
    • 5.2.15.6. Analyst View
    • 5.2.15.7. Market Share

6. Research Methodology

• 6.1. Data Sources
  • 6.1.1. Primary Data Sources
  • 6.1.2. Secondary Data Sources
  • 6.1.3. Data Triangulation
• 6.2. Market Estimation and Forecast

관련자료